JD SPORTS reported pre-tax profits of £917.2 million (€1.1 billion) in 2023 and hoped for 2024 earnings of £1 billion (€1.19 ...

This week on “The Top Line,” we break down the biggest stories out of JPM, from J&J’s blockbuster acquisition of ...

在8个月的时间里，4家大型制药公司都披露了各自的并购案：诺华斥资10亿美元收购Mariana Oncology；礼来斥资14亿美元收购Point Biopharma；阿斯利康斥资24亿美元收购Fusion Pharmaceuticals；BMS斥资41亿美元收购RayzeBio。

In pancreatic cancer, pelareorep previously demonstrated a strong efficacy signal when administered with gemcitabine, nab-paclitaxel and atezolizumab. Our new safety data indicate its ability to also ...

The J&J deal would be the biggest biotech deal in over a year and will add treatments for disorders of the central nervous ...

GSK’s share price has been pressured recently from several negative events, but this may leave a bargain to be had. I've ...

Electrical and instrumentation technology leader ABB is acquiring Dutch energy management company, Sensorfact BV ...

Gilead Sciences Inc. is moving further into inflammatory diseases in a potential $1.7 billion deal with Leo Pharma A/S around a preclinical oral signal transduction and activator of transcription 6 ...

Jemperli (dostarlimab) in combination with chemotherapy (carboplatin and paclitaxel) for first-line treatment of adult ...

The stock market can be a scary place for those who aren’t prepared. Our writer outlines three ways we might avoid getting ...

GSK (GSK) announced the European Commission has approved Jemperli, or dostarlimab, in combination with chemotherapy for first-line treatment of ...